Evidence map›Paper›PMID 41145913›Full record

ArticleThe EMBO journal2025

TET knockout cells transit between pluripotent states and exhibit precocious germline entry.

Raphaël Pantier, Elisa Barbieri, Sara Gonzalez Brito, Ella Thomson, Tülin Tatar, Douglas Colby, Man Zhang, Ian Chambers

Abstract read
In one paragraph

Article in The EMBO journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Raphaël Pantier *Centre for Regenerative Medicine, Institute for Regeneration and Repair, 5 Little France Drive, Edinburgh, EH16 4UU, Scotland.ORCID http://orcid.org/0000-0002-8394-2372
Elisa Barbieri *Centre for Regenerative Medicine, Institute for Regeneration and Repair, 5 Little France Drive, Edinburgh, EH16 4UU, Scotland.
Sara Gonzalez Brito *Centre for Regenerative Medicine, Institute for Regeneration and Repair, 5 Little France Drive, Edinburgh, EH16 4UU, Scotland.ORCID http://orcid.org/0009-0003-6199-0474
Ella ThomsonCentre for Regenerative Medicine, Institute for Regeneration and Repair, 5 Little France Drive, Edinburgh, EH16 4UU, Scotland.ORCID http://orcid.org/0000-0002-5596-3563
Tülin TatarCentre for Regenerative Medicine, Institute for Regeneration and Repair, 5 Little France Drive, Edinburgh, EH16 4UU, Scotland.
Douglas ColbyCentre for Regenerative Medicine, Institute for Regeneration and Repair, 5 Little France Drive, Edinburgh, EH16 4UU, Scotland.
Man ZhangCentre for Regenerative Medicine, Institute for Regeneration and Repair, 5 Little France Drive, Edinburgh, EH16 4UU, Scotland.
Ian ChambersCentre for Regenerative Medicine, Institute for Regeneration and Repair, 5 Little France Drive, Edinburgh, EH16 4UU, Scotland. ichambers@ed.ac.uk.ORCID http://orcid.org/0000-0003-2605-1597

Funding

EC | H2020 | PRIORITY 'Excellent science' | H2020 Marie Skłodowska-Curie Actions (MSCA) H2020-MSCAIF-2018/843879UKRI | Medical Research Council (MRC) MR/L018497/1UKRI | Medical Research Council (MRC) MR/T003162/1
6 · The paper itself

Abstract

TET1, TET2 and TET3 are DNA demethylases with important roles in development and differentiation. To assess the contributions of TET proteins to cell function during early development, single and compound knockouts of Tet genes in mouse pluripotent embryonic stem cells (ESCs) were generated. Here, we show that TET proteins are not required to transit between naïve, formative and primed pluripotency states. Moreover, ESCs with double knockouts of Tet1 and Tet2 or triple knockouts of Tet1, Tet2 and Tet3 are phenotypically indistinguishable. TET1,2,3-deficient ESCs exhibit differentiation defects and fail to activate somatic gene expression, retaining expression of pluripotency transcription factors. Therefore, TET1 and TET2, but not TET3 act redundantly to facilitate somatic differentiation. Importantly however, TET-deficient ESCs can differentiate into primordial germ cell-like cells (PGCLCs), and do so at high efficiency in the presence or absence of PGC-promoting cytokines. Moreover, acquisition of a PGCLC transcriptional programme occurs more rapidly in TET-deficient cells. These results establish that TET proteins act at the juncture between somatic and germline fates: without TET proteins, epiblast cell differentiation defaults to the germline.

Indexed as

Cell DifferentiationDNA-Binding ProteinsGerm CellsMouse Embryonic Stem CellsPluripotent Stem CellsProto-Oncogene ProteinsAnimalsDioxygenasesGene Expression Regulation, DevelopmentalGene Knockout TechniquesMiceMice, KnockoutDioxygenasesDNA-Binding ProteinsProto-Oncogene ProteinsTET1 protein, mouseTet2 protein, mouseTet3 protein, mouseDifferentiationPluripotencyPrimordial Germ CellsStem CellsTET Proteins

Identifiers

PMID41145913
PMCPMC12669618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.